Brief: Cardiff Oncology Appoints Tod Smeal As Chief Scientific Officer And Charles Monahan As Senior Vice President, Regulatory Affairs
11/01/2022 14:03
Jan 11 (Reuters) - Cardiff Oncology Inc CRDF.O :
* CARDIFF ONCOLOGY APPOINTS TOD SMEAL, PH.D., AS CHIEF
SCIENTIFIC
OFFICER AND CHARLES MONAHAN, RPH, AS SENIOR VICE PRESIDENT,
REGULATORY AFFAIRS
Source text for Eikon: ID:nPn5TNXNHa
Further company coverage: CRDF.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cardiff Oncology
See all newsBrief: Cardiff Oncology Receives FDA Orphan Drug Designation For Onvansertib In Chronic Myelomonocytic Leukemia
Corrected: Cardiff Oncology Q2 operating expenses fall on lower R&D costs
Cardiff Oncology Inc expected to post a loss of 16 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Cintas, Veradermics
Cardiff Oncology sinks on direct equity offering